Genetic and environmental factors have an influence on the process of growth and development of the body. One of numerous genetic factors can be the vitamin D receptor gene (VDR). The study aimed at evaluating the relationship between VDR polymorphism and somatic parameters in children.
The vitamin D receptor belongs to a group of nucleus receptors and is a transcriptional factor. After binding with a ligand, i.e. calcitriol [1, 25 (OH) 2 D], it forms a heterodimer with 9-cis retinoic acid receptor (RXR). The obtained complex binds to promoter loci which are dependent on the vitamin D receptor gene and inhibits or activates transcription. Variability of the vitamin D receptor gene results from its polymorphic loci: BsmI, ApaI, FokI, TruI, EcoRV, Cdx2 [7, 16] . The presence of VDR polymorphisms influences the quality of bone mineral density (osteoporosis, osteopenia, low bone mass), the size of bones and susceptibility to fractures [10, 22] . In developmental age, when the basis for diagnosing low bone mass in densitometric examination is the Z-score (sum of standard deviation scores adjusted for sex and age), it is necessary to determine the biological age of all children, including basic anthropometric parameters, such as body weight and height. In serious cases of osteoporosis in children and adolescents, bone age should also be considered [1] . In some studies on the relationship between VDR polymorphisms and the incidence of osteoporosis or low bone mass, factors of biological development are taken into consideration [2, 20] . The aim of the study was to investigate the relationship between the variability of the VDR receptor gene and body weight and height in children and adolescents.
Patients and methods
The study group consisted of 395 children, aged 6-18 years. All patients underwent genotyping using the PCR-RFLP method within polymorphic loci BsmI (rs1544410), FokI (rs2228570), ApaI (rs7975232) and TaqI (rs731236) of the VDR gene. The study was conducted in the Department of Immunopathology and Genetics in the Department of Paediatrics, Oncology, Haematology and Diabetes, at the Medical University of Łódź. Two hundred and ninety-four healthy children made up the control group in the study on the incidence of particular genotypes.
In 161 patients basic measurements of somatic development were made using standard methods. Body mass index (BMI) was calculated using the values of body weight and height (body weight (kg)/height (m)
2 ). All the obtained results were standardized for age and sex (Z-score: examined value-mean value/standard deviation) [15] . On the same day in all the children a skeletal densitometry examination was performed using dual energy X-ray absorption measurements (DXA), with the use of the Lunar Prodigy Advance device (GE Healthcare, Madison, US) with a paediatric programme. Two programmes were used: Total body and L2-L4 Spine. Bone mass density (BMD) was measured (g/cm 2 , Z-score) in both densitometric projections. The studied patients were divided into three groups depending on the DXA examination result: I -the control group, with Z-score ranging from +1.0 to -1.0; II -patients with low bone mass, Z-score ranging from -1.0 to -2.0; and III -patients with osteoporosis, Z-score<-2. 
Molecular methods
PCR reactions were performed in volumes of 20 ml: containing 0.1-0.5 ng of genomic DNA, 8 mM of dNTP, 2-3 mM of MgCl 2 , 2U of Taq DNA polymerase (TIB Molbiol, Poznan, Poland), using sets of specific oligonucleotide primers spanning the respective polymorphic loci under conditions listed in table 1. An initial period of 10 minutes at 95°C for initial denaturation and 10 minutes at 72°C for final elongation were used in all protocols.In each reaction stages of 10 minutes at 95 °C for initial denaturation and 10 minutes at 72 °C for final elongation were used. Following PCR, 6 ml of the product were digested using 0.2 U of respective enzymes and matching reaction buffers. Samples were incubated overnight at 37°C and separated using 2% agarose gel electrophoresis with ethidium bromide staining. Unique band patterns corresponding to each polymorphism were used to determine the genotype of a given patient. Table 2 presents characteristic features of the study groups: group I (Z-score ranging from -1.0 to 1.0, n=30, group II (patients with low bone mass, n=91), group III (children with osteoporosis, n=40). The average age of the patients differed significantly between the groups. Children with osteoporosis were older than those with low bone mass and those from the control group. Z-scores figure 1 . In view of the statistically significant differences between the three genotypes one may conclude that in patients with low bone mass ff genotype favours decreased body height.
Results

discussion
Vitamin D and its receptor influence calcium-phosphate metabolism and bone metabolism [2, 10, 20, 22] . The patients were divided according to bone mass criteria, introduced before [1] . The authors of the study pointed out the relationship between polymorphism for the VDR receptor gene and anthropometric measurements.
According to recently published papers, VDR has pleiotropic properties in cells of the immune and renin-angiotensin systems as well as neoplastic cells (it influences proliferation, differentiation and apoptosis) [6, 7, 11] . In consequence, there is a stronger relationship between the VDR receptor gene and rheumatoid arthritis, diabetes, hypertension, obesity, metabolic syndrome, Leśniowski-Crohn's disease, and neoplasms of the alimentary tract and skin [6, 19] . Activity of vitamin D and its receptor in overall growth cannot be described as pleiotropic. Some studies suggest that there is a relationship between VDR polymorphisms and somatic development indices [2, 20] , taken into consideration together with densitometry examination results, which are the basis for diagnosing low bone mass. In the adult population low BMI index is a confirmed factor contributing to the development of osteoporosis. Thus, it is important to make anthropometric measurements [3, 8, 13] .
The conducted analysis did not prove that there is a relationship between BsmI, ApaI and TaqI polymorphisms of the VDR receptor gene and somatic development indices. A relationship between FokI polymorphism and body height in the patients from group II (low bone mass) was noted. FF genotype contributed to increased body height in all the children, irrespective of their sex and age. The obtained results do not correspond to the results of Tao, who concluded that TT genotype of TaqI polymorphism resulted in greater body weight and increased height only in girls in preadolescence. Such an association was not observed in boys [20] . Also Suarez et al. claims that the relationship between VDR polymorphism and somatic development indices is different for boys and girls [18] . Young healthy girls (2 years old) with BB genotype (BsmI polymorphism) were characterized by greater body weight and increased height. Boys with the same genotype were characterized by lower body weight; they were also shorter and their BMI was lower as well. These associations with VDR genotype were also observed at birth and at 10 months of age in the longitudinal analysis of 145 selected full-term babies homozygous for BsmI polymorphism. The authors concluded that the VDR genotype may influence intrauterine and early postnatal growth [18] . Lorentzon et al. described the relationship between BsmI and TaqI polymorphisms of the VDR receptor gene and somatic development indices in a group of healthy Caucasian boys. Boys with the BB genotype had lower body weight at birth and grew more slowly until adolescence than their peers who had Bb and bb genotypes. In adolescence and post-adolescence the genotype contributed to decreased height (and smaller area of humeral bone, femoral bone and total body projection) [14] . Baroncelli's analysis of 209 children in preadolescence did not show any relationship between VDR polymorphism and somatic development indices [2] . Similar conclusions were drawn by Gunnes et al., who studied a group of 73 healthy girls and boys, aged 8-16.5 [5] . Also studies on Japanese girls, aged 12-15, did not show statistically significant associations of VDR polymorphism with body weight, height and BMI [9] .
Relationships between body height and VDR genotype for FokI, ApaI and TaqI polymorphisms were however observed in a group of Spanish children with bone neoplasms. Ninety-four patients (58 with bone sarcoma and 36 with Ewing's sarcoma) were taller (in comparison to the control group) and Ff genotype of FokI polymorphism appeared more frequently [17] . In the studies presented here the relationship between FokI polymorphism and body height in children with low bone mass was similar.
In the Polish adult population, according to the EPOLOS study, BsmI polymorphism of the VDR receptor gene contributes to increased body height in women in premenopausal age. Such an observation was not made in other age groups in women or in the male population [12] .
The findings obtained in a group of males with metabolic syndrome, originating from the Wrocław area, indicate that there is a relationship between the BB genotype of BsmI polymorphism and BMI index. The genotype contributed to the increase of BMI index [4] . In post-menopausal women with metabolic syndrome no statistically significant relationship between VDR genotype and somatic measurements was noted [21] . In a study of 1873 white patients Xiong et al. found a within-family associa-tion with height at BsmI and TaqI loci (p=0.048 and 0.039, respectively). Subjects with bT haplotype were on average 1% taller than those without it. The authors suggested that VDR may be associated with adult height variation in white populations [23] .
The influence of VDR polymorphisms on somatic development is one of many genetic factors determining both growth and development as well as the involution processes. Moreover, it depends on many environmental factors (geographical, social, economic, cultural). Therefore, the results obtained in various populations are different. conclusions 1. The presence of the F allele of FokI polymorphism of the VDR receptor gene favours increased body height, which is best observed in children with low bone mass.
2.
FF genotype favours increased body height in the studied group of children from Łódź.
